I'm LongbridgeAI, I can summarize articles.Regeneron Pharmaceuticals (REGN) shares fell 1.48% to $781.49 on Friday, underperforming the broader market and competitors like Moderna amid a positive trading session. This marks the stock's sixth consecutive day of losses, closing 9.06% below its 52-week high. Trading volume was significantly lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 1.48% to $781.49 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.86% to 7,656.98 and the Dow Jones Industrial Average rising 0.98% to 52,573.29.
This was the stock's sixth consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 9.06% below its 52-week high of $859.34, which the company reached on September 3rd.
The stock underperformed when compared to some of its competitors Friday, as Amgen Inc. (AMGN) fell 1.34% to $377.35, Moderna Inc. (MRNA) rose 5.38% to $143.97, and Gilead Sciences Inc. (GILD) fell 0.75% to $143.72.
Trading volume (439,006) remained 304,827 below its 50-day average volume of 743,833.
Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-11-26 1642ET